Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

AERIE PHARMACEUTICALS INC (AERI) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $7.49 Metrics
OS: 49.4 M
Market cap: $370 M -15 % ROIC
Net debt: $128 M
EV: $497 M

 
TTM Valuation
EBITDA
EBIT ($32.4) M
EPS ($1.06)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
Revenues194.183.169.924.20.00.00.00.0
            Revenue growth133.5%19.0%189.0%     
Cost of goods sold26.825.34.80.616.79.80.00.0
Gross profit167.357.865.123.5-16.7-9.80.00.0
            Gross margin86.2%69.5%93.1%97.3%    
Selling, general and administrative137.8137.2138.4120.656.934.730.6 
Research and development75.874.091.486.172.152.444.529.9
General and administrative       20.1
EBITA-15.3-127.9-174.5-208.1-145.4-96.9-75.1-50.0
            EBITA margin-7.9%-153.8%-249.7%-860.6%    
Amortization of intangibles31.127.813.01.60.3   
EBIT-46.4-155.7-187.5-209.7-145.7-96.9-75.1-50.0
            EBIT margin-23.9%-187.3%-268.3%-867.4%    
Pre-tax income-74.2-177.9-199.7-232.6-146.9-98.9-74.2-48.1
Income taxes0.65.2-0.10.0-1.80.20.10.0
            Tax rate  0.0% 1.2%  0.0%
Net income-74.8-183.1-199.6-232.6-145.1-99.1-74.4-48.1
            Net margin-38.5%-220.2%-285.6%-961.8%    
 
Diluted EPS($1.61)($3.99)($4.39)($5.58)($4.11)($3.40)($2.88)($2.00)
Shares outstanding (diluted)46.345.945.441.735.329.125.824.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy